Your browser doesn't support javascript.
loading
Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS.
Yang, Yue; Rowe, Dominic; McCann, Heather; Shepherd, Claire E; Kril, Jillian J; Kiernan, Matthew C; Halliday, Glenda M; Tan, Rachel H.
Affiliation
  • Yang Y; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Rowe D; Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Camperdown, New South Wales, Australia.
  • McCann H; Macquarie University Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Shepherd CE; Neuroscience Research Australia, Randwick, New South Wales, Australia.
  • Kril JJ; Neuroscience Research Australia, Randwick, New South Wales, Australia.
  • Kiernan MC; Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Camperdown, New South Wales, Australia.
  • Halliday GM; Dementia Research Centre, Macquarie Medical School, Macquarie University, Sydney, New South Wales, Australia.
  • Tan RH; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Neuropathol Appl Neurobiol ; 49(4): e12919, 2023 08.
Article in En | MEDLINE | ID: mdl-37317638
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Type of study: Prognostic_studies Limits: Animals Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Type of study: Prognostic_studies Limits: Animals Language: En Year: 2023 Type: Article